About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lymphoma Clinical Trials in Austin | 151 Studies

Clinical Trials LymphomaAustin

Lymphoma Clinical Trials in Austin

Find 151 clinical trials for lymphoma near Austin, Texas. Connect with research centers in your area.

All Lymphoma trials nationwide All trials in Austin

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 61-80 of 151 trials

Active not recruitingA Study of TAK-007 in Adults With Relapsed or Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)This study has 2 parts.NCT05020015·Birmingham, Alabama and 14 others CompletedCollecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin LymphomaThis research study is collecting and storing tissue samples from patients with rare or cutaneous non-Hodgkin lymphoma.NCT01000753·Birmingham, Alabama and 129 others

Lymphoma Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedTisagenlecleucel in Adult Patients With Aggressive B-cell Non-Hodgkin LymphomaThis is a randomized, open label, multicenter phase III trial comparing the efficacy, safety, and tolerability of tisagenlecleucel to Standard Of Care in adult patients with…NCT03570892·La Jolla, California and 66 others

CompletedStudy of Ibrutinib Combined With Venetoclax in Subjects With Mantle Cell Lymphoma (MCL)This Phase 3 multinational, randomized, double-blind study is designed to compare the efficacy and safety of the combination of ibrutinib and venetoclax vs. ibrutinib and placebo…NCT03112174·Tucson, Arizona and 119 others

CompletedStudy of Lenalidomide Maintenance Versus Placebo in Responding Elderly Patients With DLBCL and Treated With R-CHOPThis study is designed as a phase III, randomized, double-blind, placebo-controlled trial to explore the effect of maintenance therapy with lenalidomide versus placebo on…NCT01122472·Bendigo and 156 others

Active not recruitingIvosidenib in Treating Patients With Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With IDH1 Mutations (A Pediatric MATCH Treatment Trial)This phase II Pediatric MATCH trial studies how well ivosidenib works in treating patients with solid tumors, including central nervous system tumors, lymphomas and histiocytic…NCT04195555·Birmingham, Alabama and 173 others

Active not recruitingA Study of JNJ-90014496 in Participants With B-Cell Non-Hodgkin LymphomaThis is a Phase 1b/2, multicenter, open-label, study of JNJ-90014496, an autologous dual targeting chimeric antigen receptor (CAR) T-cell therapy targeting both cluster of…NCT05421663·Duarte, California and 31 others

Approved for marketingAn Open Label Treatment Use Protocol for Ibrutinib in Subjects With Relapsed or Refractory Mantle Cell LymphomaThe purpose of this study is to provide patients who have relapsed or refractory Mantle Cell Lymphoma (MCL) with early access to an investigational medication called ibrutinib…NCT01833039·Phoenix, Arizona and 50 others

CompletedStudy of STRO-001, an Anti-CD74 Antibody Drug Conjugate, in Patients With Advanced B-Cell MalignanciesFirst-in-human Phase 1 trial to study the safety, pharmacokinetics and preliminary efficacy of STRO-001 given intravenously every 3 weeks.NCT03424603·Birmingham, Alabama and 21 others

RecruitingA Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell TherapyThis Phase 3 study compares rondecabtagene autoleucel (ronde-cel), a dual-targeting CD19/CD20 CAR T-cell therapy, with investigator's choice of CD19 CAR T-cell therapy in patients…NCT07188558·Gilbert, Arizona and 43 others

Not yet recruitingRadiotherapy in Combination With Glofitamab in Relapsed/Refractory Diffuse Large B Cell LymphomaThe goal of this clinical trial is to see if a new combination of standard of care radiotherapy treatment prior to administering the study drugs obinutuzumab and glofitamab in…NCT07634289·Douglas, Queensland and 4 others

CompletedPalbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial)This phase II Pediatric MATCH trial studies how well palbociclib works in treating patients with Rb positive solid tumors, non-Hodgkin lymphoma, or histiocytic disorders with…NCT03526250·Birmingham, Alabama and 116 others

RecruitingRole of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Dosing Immunoglobulin (Dose Ig)This study is being conducted to find out how safe and effective different strategies of infection prevention are in comparison to each other, for preventing infection in patients…NCT07202065·Adelaide, South Australia and 2 others

CompletedA Trial of Radiotherapy and Durvalumab in DLBCL and FLThe primary objective for this study is to determine the safety profile of radiotherapy and durvalumab, a PD-L1 inhibitor.NCT03610061·Brisbane, Queensland and 2 others

CompletedEvaluate Safety and Tolerability of Calcipotriene Foam 0.005% in Pediatric Subjects With Mild/Moderate Plaque PsoriasisCalcipotriene is a vitamin D3 analog that has been used as topical therapy in adult subjects with plaque-type psoriasis since 1993.NCT01582932·Birmingham, Alabama and 35 others

CompletedSelumetinib Sulfate in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)This phase II Pediatric MATCH trial studies how well selumetinib sulfate works in treating patients with solid tumors, non-Hodgkin lymphoma, or histiocytic disorders with MAPK…NCT03213691·Birmingham, Alabama and 109 others

CompletedBlood Sample Markers of Reproductive Hormones in Assessing Ovarian Reserve in Younger Patients With Newly Diagnosed LymphomasThis clinical trial studies blood sample markers of reproductive hormones in assessing ovarian reserve in younger patients with newly diagnosed lymphomas.NCT01793233·Birmingham, Alabama and 106 others

CompletedPhase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental AreaTo evaluate the safety and efficacy of deoxycholic acid injection in the reduction of submental fat (fat below the chin).NCT01546142·Little Rock, Arkansas and 34 others

CompletedRituximab in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Follicular Non-Hodgkin's LymphomaRATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growth in different ways. Some block the ability of cancer cells to grow and spread.NCT00112931·Adelaide and 71 others

Active not recruitingStudy of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Previously Untreated Follicular LymphomaFollicular lymphoma (FL) is the second most common B-cell cancer and the most common type of cancer of lymphocytes.NCT06191744·Fresno, California and 265 others

PreviousPage 4 of 8Next

Other Conditions in Austin

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia